glp-1 and breast cancer risk Receptor Agonists Show a Striking Signal in Outcomes, but Big Questions Remain GLP-1s in Breast Cancer: Overall

Consistency is key: injections are taken once a week on the same day

How pricing works: Injectable GLP-1s through TrumpRX may cost eligible patients $50 to $350/month, depending on insurance coverage or program eligibility

Compared with DPP-4i users, GLP-1 RA users were younger (mean age 56.1 vs 62.3 years), had a higher body mass index (36.5 vs 32.1 kg/m), and were less likely to be male (45.2% vs 50.4%)

J Bone Miner Res (2013) 28(7):164152

The Chinese government has included the NMPA-approved GLP-1 receptor agonists in the national medical insurance policy to increase the accessibility and affordability of such drugs